Spots Global Cancer Trial Database for stage iii prostate cancer ajcc v8

Every month we try and update this database with for stage iii prostate cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma	NCT04945642	Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	High-Dose Rate ... Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial	NCT06016725	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost...	Exercise Interv... Informational I... Nutritional Ass... Physical Perfor... Quality-of-Life... Questionnaire A...	65 Years -	Ohio State University Comprehensive Cancer Center
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans	NCT04215029	Cancer Survivor Partner Spouse Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Exercise Interv... Informational I... Informational I... Interview Nutritional Ass... Questionnaire A... Telephone-Based...	18 Years -	M.D. Anderson Cancer Center
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy	NCT04288336	Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Food Diary Preventative Di... Questionnaire A...	18 Years -	Mayo Clinic
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer	NCT06129851	Stage IIC Prost... Stage III Prost... Stage IV Prosta...	Biospecimen Col... Bone Scan Brachytherapy Computed Tomogr... Dual X-ray Abso... External Beam R... Magnetic Resona... PSMA PET Scan Questionnaire A... Relugolix	18 Years -	University of Kansas Medical Center
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer	NCT04725903	Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	High-Dose Rate ... Proton Beam Rad... Quality-of-Life... Survey Administ...	18 Years -	Emory University
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy	NCT04927559	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Survey Administ...	18 Years -	University of Southern California
RElugolix VErsus LeUprolide Cardiac Trial	NCT05320406	Biochemically R... Localized Prost... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Radiation thera... Leuprolide Relugolix	18 Years -	Emory University
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion	NCT04976257	Prostate Adenoc... Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Angiogram Catheterization Gallium Ga-labe... Positron Emissi...	18 Years - 80 Years	University of California, San Francisco
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV	NCT04514484	Advanced Differ... Advanced Head a... Advanced Hepato... Advanced Kaposi... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Melano... Advanced Ovaria... Advanced Prosta... Advanced Renal ... Advanced Thyroi... Advanced Triple... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HIV Infection Metastatic Diff... Metastatic Head... Metastatic Hepa... Metastatic Kapo... Metastatic Lung... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Pros... Metastatic Rena... Metastatic Thyr... Metastatic Trip... Metastatic Urot... Recurrent Diffe... Recurrent Head ... Recurrent Hepat... Recurrent Kapos... Recurrent Lung ... Recurrent Lung ... Recurrent Malig... Recurrent Melan... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Thyro... Recurrent Tripl... Recurrent Uroth... Refractory Diff... Stage III Diffe... Stage III Hepat... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Thyro... Stage IV Differ... Stage IV Hepato... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Thyroi...	Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer	NCT03581500	Prostate Adenoc... PSA Level Great... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hyperpolarized ... Magnetic Resona...	-	M.D. Anderson Cancer Center
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery	NCT03218826	Advanced Breast... Advanced Malign... Advanced Prosta... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Metastatic Brea... Metastatic Mali... Metastatic Pros... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Triple-Negative... Unresectable So...	Docetaxel Laboratory Biom... Pharmacological... PI3Kbeta Inhibi...	18 Years -	National Cancer Institute (NCI)
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study	NCT03707574	Advanced Malign... Advanced Melano... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Lung... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVA Color... Stage IVA Lung ... Stage IVA Ovari... Stage IVA Prost... Stage IVB Color... Stage IVB Lung ... Stage IVB Ovari... Stage IVB Prost... Stage IVC Color...	Biospecimen Col...	18 Years -	National Cancer Institute (NCI)
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans	NCT04215029	Cancer Survivor Partner Spouse Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Exercise Interv... Informational I... Informational I... Interview Nutritional Ass... Questionnaire A... Telephone-Based...	18 Years -	M.D. Anderson Cancer Center
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer	NCT04318028	Non-Metastatic ... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	7 Tesla Magneti...	18 Years -	University of Southern California
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer	NCT04947254	Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Abiraterone Ace... Antiandrogen Th... Apalutamide Biopsy Niraparib Prednisone Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	NCT05946213	Stage III Prost... Stage IVA Prost...	External Beam R... Stereotactic Bo...	18 Years -	NRG Oncology
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer	NCT06094842	Prostate Carcin... Prostate Small ... Stage III Prost... Stage IV Prosta...	Bendamustine Biopsy Biospecimen Col... Bone Scan Bridge Therapy Computed Tomogr... Cyclophosphamid... Echocardiograph... Fludarabine Leukapheresis Multigated Acqu... T-cell Receptor... X-Ray Imaging	18 Years -	Fred Hutchinson Cancer Center
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors	NCT03784677	Advanced Malign... Refractory Mali... Refractory Ovar... Refractory Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Ovari... Stage IVA Prost... Stage IVB Ovari... Stage IVB Prost...	TRPV6 Calcium C...	18 Years -	M.D. Anderson Cancer Center
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	NCT05946213	Stage III Prost... Stage IVA Prost...	External Beam R... Stereotactic Bo...	18 Years -	NRG Oncology
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation	NCT05487846	Metastatic Pros... Stage III Prost... Stage IV Prosta...	Patient Navigat... Genetic Counsel... Survey Administ... Best Practice Genetic Counsel... Survey Administ...	18 Years -	Thomas Jefferson University
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery	NCT03899987	Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Aspirin Radical Prostat... Recombinant Int... Rintatolimod	18 Years -	Roswell Park Cancer Institute
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy	NCT05869682	Advanced Prosta... Metastatic Pros... Prostate Carcin... Stage III Prost... Stage IV Prosta...	Bright White Li... Combination Dru... Electronic Heal... Quality-of-Life... Questionnaire A...	60 Years -	City of Hope Medical Center
EXERCISING TOGETHER for Couples Coping With Cancer	NCT03630354	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Carcinom... Colorectal Carc... Malignant Solid... Prostate Carcin... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost...	Exercise Interv... Exercise Interv... Informational I... Questionnaire A...	35 Years - 80 Years	OHSU Knight Cancer Institute
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy	NCT04288336	Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Food Diary Preventative Di... Questionnaire A...	18 Years -	Mayo Clinic
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy	NCT04927559	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Survey Administ...	18 Years -	University of Southern California
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer	NCT04725903	Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	High-Dose Rate ... Proton Beam Rad... Quality-of-Life... Survey Administ...	18 Years -	Emory University
Low-Intensity Shockwave Therapy to Treat Erectile Dysfunction and Preserve Erectile Function After Prostate Cancer Surgery	NCT05877144	Erectile Dysfun... Localized Prost... Stage I Prostat... Stage II Prosta... Stage III Prost...	Nerve-Sparing P... Medical Device ... Duplex Ultrasou... Survey Administ... Nerve-Sparing P... Sham Interventi... Duplex Ultrasou... Survey Administ...	18 Years - 80 Years	Thomas Jefferson University
Low-Intensity Shockwave Therapy to Treat Erectile Dysfunction and Preserve Erectile Function After Prostate Cancer Surgery	NCT05877144	Erectile Dysfun... Localized Prost... Stage I Prostat... Stage II Prosta... Stage III Prost...	Nerve-Sparing P... Medical Device ... Duplex Ultrasou... Survey Administ... Nerve-Sparing P... Sham Interventi... Duplex Ultrasou... Survey Administ...	18 Years - 80 Years	Thomas Jefferson University
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners	NCT03575832	Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Counseling Informational I... Quality-of-Life... Questionnaire A... Telephone-Based...	18 Years -	M.D. Anderson Cancer Center
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial	NCT06016725	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost...	Exercise Interv... Informational I... Nutritional Ass... Physical Perfor... Quality-of-Life... Questionnaire A...	65 Years -	Ohio State University Comprehensive Cancer Center
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers	NCT05722288	Localized Prost... Locally Advance... Locally Advance... Malignant Solid... Recurrent Prost... Stage I Prostat... Stage IB Cervic... Stage IB2 Cervi... Stage II Prosta... Stage II Rectal... Stage IIA Cervi... Stage IIB Cervi... Stage III Prost... Stage III Recta... Stage IIIA Cerv... Stage IIIB Cerv... Stage IIIC Cerv... Stage IVA Prost...	Biospecimen Col... Informational I... Quality-of-Life... Questionnaire A... Short-Term Fast...	18 Years -	City of Hope Medical Center
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy	NCT03570827	Prostate Adenoc... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Androgen Suppre... Hypofractionate... Quality-of-Life... Questionnaire A...	18 Years -	Mayo Clinic
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes	NCT04501913	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Hepatobiliary N... Malignant Diges... Malignant Femal... Malignant Genit... Malignant Neopl... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage 0 Colorec... Stage 0a Bladde... Stage 0is Bladd... Stage I Bladder... Stage I Cervica... Stage I Colorec... Stage I Ovarian... Stage I Prostat... Stage I Renal C... Stage I Uterine... Stage IA Cervic... Stage IA Ovaria... Stage IA Uterin... Stage IA1 Cervi... Stage IA2 Cervi... Stage IB Cervic... Stage IB Ovaria... Stage IB Uterin... Stage IB1 Cervi... Stage IB2 Cervi... Stage IC Ovaria... Stage II Bladde... Stage II Cervic... Stage II Colore... Stage II Ovaria... Stage II Prosta... Stage II Renal ... Stage II Uterin... Stage IIA Cervi... Stage IIA Color... Stage IIA Ovari... Stage IIA Prost... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Color... Stage IIB Ovari... Stage IIB Prost... Stage IIC Color... Stage IIC Prost... Stage III Bladd... Stage III Cervi... Stage III Color... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Blad... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Blad... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Bladde... Stage IV Cervic... Stage IV Colore... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Bladd... Stage IVA Cervi... Stage IVA Color... Stage IVA Ovari... Stage IVA Prost... Stage IVA Uteri... Stage IVB Bladd... Stage IVB Cervi... Stage IVB Color... Stage IVB Ovari... Stage IVB Prost... Stage IVB Uteri... Stage IVC Color...	Patient Monitor... Questionnaire A...	18 Years -	City of Hope Medical Center
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate	NCT03582475	Bladder Small C... Castration-Resi... Metastatic Blad... Metastatic Uret... Prostate Carcin... Prostate Neuroe... Prostate Small ... Stage III Bladd... Stage III Prost... Stage III Ureth... Stage IV Bladde... Stage IV Prosta... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Ureter Small Ce... Urothelial Carc...	Carboplatin Cisplatin Docetaxel Etoposide Pembrolizumab	18 Years -	Jonsson Comprehensive Cancer Center
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer	NCT04067960	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Biliary Tract C... Clinical Stage ... Clinical Stage ... Malignant Brain... Malignant Genit... Malignant Solid... Pancreatobiliar... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Color... Stage IVA Ovari... Stage IVA Pancr... Stage IVA Prost... Stage IVB Color... Stage IVB Ovari... Stage IVB Pancr... Stage IVB Prost... Stage IVC Color...	Biospecimen Col... Genetic Testing Quality-of-Life... Questionnaire A...	-	Mayo Clinic
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer	NCT04134260	Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Apalutamide Hormone Therapy Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	NRG Oncology
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer	NCT06173362	Advanced Prosta... Stage III Prost... Stage IV Prosta...	Abiraterone Biospecimen Col... Darolutamide Prednisone	18 Years -	University of California, Davis
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer	NCT04981834	Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Quality-of-Life... Questionnaire A... Radical Prostat... Vesicopexy	18 Years -	University of Southern California
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	NCT04550494	Advanced Pancre... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HER2-Positive B... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Brea... Metastatic Gast... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Pros... Platinum-Sensit... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Talazoparib	18 Years -	National Cancer Institute (NCI)
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners	NCT04189770	Cancer Survivor Partner Spouse Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Accelerometer Ecological Mome... Questionnaire A... Survey Administ...	18 Years -	M.D. Anderson Cancer Center
RElugolix VErsus LeUprolide Cardiac Trial	NCT05320406	Biochemically R... Localized Prost... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Radiation thera... Leuprolide Relugolix	18 Years -	Emory University
Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer	NCT06325046	Localized Prost... Stage I Prostat... Stage II Prosta... Stage III Prost...	Computed Tomogr... Cone-Beam Compu... Image-Guided Ad... Magnetic Resona... Stereotactic Ab... Survey Administ...	18 Years -	Mayo Clinic
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer	NCT04037254	Prostate Adenoc... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Gonadotrophin R... Intensity-Modul... Niraparib	18 Years -	NRG Oncology
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners	NCT04189770	Cancer Survivor Partner Spouse Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros...	Accelerometer Ecological Mome... Questionnaire A... Survey Administ...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: